Showing 1 to 12 of 22 results


Trump's Misleading Claim of 1000% Prescription Drug Price Reduction
President Trump repeatedly claims his "most favored nation" policy will cut prescription drug prices by 1000% or more, a mathematically impossible assertion; this claim is factually inaccurate, as a 100% reduction would mean the price drops to zero.
Trump's Misleading Claim of 1000% Prescription Drug Price Reduction
President Trump repeatedly claims his "most favored nation" policy will cut prescription drug prices by 1000% or more, a mathematically impossible assertion; this claim is factually inaccurate, as a 100% reduction would mean the price drops to zero.
Progress
44% Bias Score


Low Enrollment in Medicare's New Prescription Payment Plan
The Inflation Reduction Act's $2,000 cap on Part D out-of-pocket drug costs in 2025 introduced the voluntary Medicare Prescription Payment Plan (MPPP), allowing enrollees to spread payments monthly; however, only 16% of the 1.2 million eligible beneficiaries enrolled by February 2025.
Low Enrollment in Medicare's New Prescription Payment Plan
The Inflation Reduction Act's $2,000 cap on Part D out-of-pocket drug costs in 2025 introduced the voluntary Medicare Prescription Payment Plan (MPPP), allowing enrollees to spread payments monthly; however, only 16% of the 1.2 million eligible beneficiaries enrolled by February 2025.
Progress
36% Bias Score


Rite Aid Bankruptcy: Store Closures and Asset Sale to Competitors
Rite Aid, facing a second bankruptcy, is closing 142 stores and selling its pharmacy assets to CVS, Walgreens, and others, ensuring prescription transfers but raising concerns about healthcare access.
Rite Aid Bankruptcy: Store Closures and Asset Sale to Competitors
Rite Aid, facing a second bankruptcy, is closing 142 stores and selling its pharmacy assets to CVS, Walgreens, and others, ensuring prescription transfers but raising concerns about healthcare access.
Progress
48% Bias Score


Trump Signs Executive Order to Slash Prescription Drug Prices
President Trump signed an executive order on Monday implementing a 'most favored nation' policy to lower U.S. prescription drug prices to match the lowest prices paid internationally, targeting high-cost drugs like Ozempic and aiming for a 59% price reduction.
Trump Signs Executive Order to Slash Prescription Drug Prices
President Trump signed an executive order on Monday implementing a 'most favored nation' policy to lower U.S. prescription drug prices to match the lowest prices paid internationally, targeting high-cost drugs like Ozempic and aiming for a 59% price reduction.
Progress
64% Bias Score


Trump to Issue Executive Order Lowering Prescription Drug Prices
President Trump will sign an executive order next week to lower prescription drug prices by implementing a 'most favored nation' pricing model for Medicare, potentially saving billions and impacting millions of Americans while facing significant industry opposition.
Trump to Issue Executive Order Lowering Prescription Drug Prices
President Trump will sign an executive order next week to lower prescription drug prices by implementing a 'most favored nation' pricing model for Medicare, potentially saving billions and impacting millions of Americans while facing significant industry opposition.
Progress
40% Bias Score


Major Retailers Expand Same-Day Prescription Delivery Nationwide
Amazon and Walmart are expanding same-day prescription delivery nationwide, joining CVS and Walgreens in a trend driven by rising telemedicine use and the closure of traditional pharmacies; however, cost and insurance coverage remain major obstacles to widespread adoption.
Major Retailers Expand Same-Day Prescription Delivery Nationwide
Amazon and Walmart are expanding same-day prescription delivery nationwide, joining CVS and Walgreens in a trend driven by rising telemedicine use and the closure of traditional pharmacies; however, cost and insurance coverage remain major obstacles to widespread adoption.
Progress
36% Bias Score

Medicare Part D Premiums Set to Surge Up to $50 Monthly
Medicare Part D enrollees face potential monthly premium increases up to \$50 in 2024 due to rising drug costs, the Inflation Reduction Act's cost shift to insurers, and reduced government funding for premium stabilization, prompting experts to urge beneficiaries to compare plans during open enrollm...

Medicare Part D Premiums Set to Surge Up to $50 Monthly
Medicare Part D enrollees face potential monthly premium increases up to \$50 in 2024 due to rising drug costs, the Inflation Reduction Act's cost shift to insurers, and reduced government funding for premium stabilization, prompting experts to urge beneficiaries to compare plans during open enrollm...
Progress
40% Bias Score

White House to Correct Errors in Kennedy's Health Report
The White House will correct errors found in Robert F. Kennedy Jr.'s "Make America Healthy Again" report, which contained seven unverifiable studies among more than 500 citations, concerning children's screen time, medication use and anxiety; the report is meant to be used to develop policy recommen...

White House to Correct Errors in Kennedy's Health Report
The White House will correct errors found in Robert F. Kennedy Jr.'s "Make America Healthy Again" report, which contained seven unverifiable studies among more than 500 citations, concerning children's screen time, medication use and anxiety; the report is meant to be used to develop policy recommen...
Progress
52% Bias Score

Trump's Executive Order Targets High Prescription Drug Costs
President Trump signed an executive order on Monday aiming to cut US prescription drug prices by at least 59% within 30 days, accusing Germany and the EU of forcing lower drug prices in Europe, leading to higher costs in the US, and threatening manufacturers with Medicare payment limits for non-comp...

Trump's Executive Order Targets High Prescription Drug Costs
President Trump signed an executive order on Monday aiming to cut US prescription drug prices by at least 59% within 30 days, accusing Germany and the EU of forcing lower drug prices in Europe, leading to higher costs in the US, and threatening manufacturers with Medicare payment limits for non-comp...
Progress
56% Bias Score

Trump Announces Executive Order to Slash Prescription Drug Prices
President Trump announced he will sign an executive order on Monday to reduce prescription drug prices in the US by 30-80% by implementing a "most favored nation" policy that matches US prices to the lowest globally, potentially saving trillions and impacting global pharmaceutical markets.

Trump Announces Executive Order to Slash Prescription Drug Prices
President Trump announced he will sign an executive order on Monday to reduce prescription drug prices in the US by 30-80% by implementing a "most favored nation" policy that matches US prices to the lowest globally, potentially saving trillions and impacting global pharmaceutical markets.
Progress
60% Bias Score

Trump Executive Order Seeks to Alter Medicare Drug Pricing, Faces Uphill Battle
President Trump signed an executive order potentially delaying small molecule drug price negotiations under the Inflation Reduction Act by up to four years, raising concerns about budget neutrality, legal challenges under the revised Chevron Doctrine, and political opposition.

Trump Executive Order Seeks to Alter Medicare Drug Pricing, Faces Uphill Battle
President Trump signed an executive order potentially delaying small molecule drug price negotiations under the Inflation Reduction Act by up to four years, raising concerns about budget neutrality, legal challenges under the revised Chevron Doctrine, and political opposition.
Progress
36% Bias Score

CMS Raises Medicare Advantage Reimbursement Rate by 5.06%, Adding $25 Billion
CMS raised the 2026 Medicare Advantage reimbursement rate by 5.06%, adding $25 billion, reversing previous cuts that eliminated plans covering 1.5 million beneficiaries in 2025 and led to higher costs and fewer benefits; CMS also withdrew a proposal to expand coverage for obesity drugs.

CMS Raises Medicare Advantage Reimbursement Rate by 5.06%, Adding $25 Billion
CMS raised the 2026 Medicare Advantage reimbursement rate by 5.06%, adding $25 billion, reversing previous cuts that eliminated plans covering 1.5 million beneficiaries in 2025 and led to higher costs and fewer benefits; CMS also withdrew a proposal to expand coverage for obesity drugs.
Progress
44% Bias Score
Showing 1 to 12 of 22 results